Online Instruction Types: O'Connor
Sipuleucel T Presentation Anna Begelfer Ostrovski
1 Improving FDA/Industry Interactions: Suggestions from FDA/CDER Statisticians Rafia Bhore, Ph.D. Janice Derr, Ph.D. FDA / CDER / Office of Biostatistics.
Critical period hypothesis
BZDs Patients Substance Abuse97-03Mode
On The Tandem (+) Project Integration with INSPIRE (ESDI) Lars H. Backer Statistics Sweden and the Tandem consortium.